Processa Pharmaceuticals, Inc. SEC filings PCSA
Processa Pharmaceuticals, Inc. has 705 filings in SEC EDGAR's recent list, going back to Oct 28, 2011. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Oct 9, 2026 | — |
| S-8 | Employee stock plan registration | Sep 22, 2025 | — |
| 424B5 | Prospectus supplement | Jul 25, 2025 | — |
| 424B4 | Prospectus | Jun 18, 2025 | — |
| S-1 | Registration statement | Jun 13, 2025 | — |
| 424B4 | Prospectus | Jan 29, 2025 | — |
| S-1/A | Amended registration statement | Jan 27, 2025 | — |
| S-1/A | Amended registration statement | Jan 16, 2025 | — |
| S-1 | Registration statement | Dec 20, 2024 | — |
| S-8 | Employee stock plan registration | Jul 22, 2024 | — |
| 424B5 | Prospectus supplement | May 28, 2024 | — |
| S-3 | Shelf registration | May 21, 2024 | — |
| 424B4 | Prospectus | Jan 29, 2024 | — |
| S-1/A | Amended registration statement | Jan 22, 2024 | — |
| S-1 | Registration statement | Dec 29, 2023 | — |
| 424B5 | Prospectus supplement | Feb 13, 2023 | — |
| S-8 | Employee stock plan registration | Aug 16, 2022 | — |
| 424B5 | Prospectus supplement | Mar 24, 2022 | — |
| 424B5 | Prospectus supplement | Aug 20, 2021 | — |
| S-3 | Shelf registration | Jun 30, 2021 | — |
| S-8 | Employee stock plan registration | Jun 30, 2021 | — |
| 424B3 | Prospectus | Apr 12, 2021 | — |
| S-3 | Shelf registration | Apr 2, 2021 | — |
| 424B4 | Prospectus | Oct 5, 2020 | — |
| S-1MEF | Filing | Oct 1, 2020 | — |
| S-1/A | Amended registration statement | Sep 30, 2020 | — |
| S-1/A | Amended registration statement | Sep 17, 2020 | — |
| S-1/A | Amended registration statement | Jul 17, 2020 | — |
| S-1 | Registration statement | Dec 13, 2019 | — |
| S-8 | Employee stock plan registration | Aug 14, 2019 | — |
| 424B3 | Prospectus | Nov 14, 2018 | — |
| 424B3 | Prospectus | Nov 9, 2018 | — |
| S-1/A | Amended registration statement | Oct 30, 2018 | — |
| S-1/A | Amended registration statement | Oct 9, 2018 | — |
| S-1/A | Amended registration statement | Sep 14, 2018 | — |
| S-1 | Registration statement | Jul 30, 2018 | — |
| S-8 | Employee stock plan registration | Aug 16, 2013 | — |
| 424B3 | Prospectus | Jun 6, 2013 | — |
| S-1/A | Amended registration statement | May 23, 2013 | — |
| S-1/A | Amended registration statement | May 15, 2013 | — |
| S-1/A | Amended registration statement | Apr 11, 2013 | — |
| S-1/A | Amended registration statement | Mar 14, 2013 | — |
| S-1/A | Amended registration statement | Jan 11, 2013 | — |
| S-1 | Registration statement | Nov 14, 2012 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PCSA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Vero Beach, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1533743
- Former names
- Heatwurx, Inc. (until Oct 20, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.